These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6232035)

  • 1. Etodolac, aspirin, and gastrointestinal microbleeding.
    Arnold JD; Mullane JF; Hayden DM; March L; Hart K; Perdomo CA; Fencik M; Berger AE
    Clin Pharmacol Ther; 1984 May; 35(5):716-21. PubMed ID: 6232035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etodolac, a new nonsteroidal anti-inflammatory drug: gastrointestinal microbleeding and endoscopic studies.
    Lanza FL; Arnold JD
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():5-15. PubMed ID: 2525983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal microbleeding associated with the use of etodolac, ibuprofen, indomethacin, and naproxen in normal males.
    Salom IL; Jacob G; Jallad N; Perdomo CA; Mullane JF; Weidler D
    J Clin Pharmacol; 1984; 24(5-6):240-6. PubMed ID: 6235249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal blood loss in arthritic patients receiving chronic dosing with etodolac and piroxicam.
    Jallad NS; Sanda M; Salom IL; Perdomo CS; Garg DC; Mullane JF; Weidler DJ
    Am J Med Sci; 1986 Nov; 292(5):272-6. PubMed ID: 2946224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of etodolac SR and naproxen on gastro-intestinal blood loss.
    Leese P
    Curr Med Res Opin; 1992; 13(1):13-20. PubMed ID: 1468240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etodolac compared with aspirin: an endoscopic study of the gastrointestinal tracts of normal volunteers.
    Lanza F; Panagides J; Salom IL
    J Rheumatol; 1986 Apr; 13(2):299-303. PubMed ID: 2941572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimum effective dose of etodolac for the treatment of rheumatoid arthritis.
    Jacob G; Messina M; Kennedy J; Epstein C; Sanda M; Mullane J
    J Clin Pharmacol; 1986 Mar; 26(3):195-202. PubMed ID: 2937811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of etodolac, aspirin and placebo for pain after oral surgery.
    Gaston GW; Mallow RD; Frank JE
    Pharmacotherapy; 1986; 6(5):199-205. PubMed ID: 2948162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative gastrointestinal blood loss associated with placebo, aspirin, and nabumetone as assessed by radiochromium (51Cr).
    Lussier A; Davis A; Lussier Y; Lebel E
    J Clin Pharmacol; 1989 Mar; 29(3):225-9. PubMed ID: 2786009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etodolac, aspirin, and placebo in patients with rheumatoid arthritis: a 12-week study.
    Edwards W
    Clin Ther; 1983; 5(5):495-503. PubMed ID: 6225520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of gastrointestinal microbleeding caused by aspirin, fenbufen, and placebo.
    Lussier A; Tétreault L; Lebel E
    Am J Med; 1983 Oct; 75(4B):80-3. PubMed ID: 6605682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the upper gastrointestinal effects of etodolac and aspirin in healthy dogs.
    Nishihara K; Kikuchi H; Kanno T; Tanabe S; Sarashina T; Uzuka Y
    J Vet Med Sci; 2001 Oct; 63(10):1131-3. PubMed ID: 11714031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal blood loss of oxaprozin and aspirin with placebo control.
    Lussier A; LeBel E; Tétreault L
    J Clin Pharmacol; 1982 Apr; 22(4):173-8. PubMed ID: 6980231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiochromium (chromium-51) evaluation of gastrointestinal blood loss associated with placebo, aspirin, and nabumetone.
    Lussier A; LeBel E
    Am J Med; 1987 Oct; 83(4B):15-8. PubMed ID: 3500642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etodolac, aspirin, and placebo in patients with degenerative joint disease: a twelve-week study.
    Andelman SY
    Clin Ther; 1983; 5(6):651-61. PubMed ID: 6226358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etodolac in postsurgical pain: a double-blind dose-ranging efficacy study with aspirin and placebo.
    Versichelen L; Bilsback P; Rolly G; Merlo M; Joubert L
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):236-9. PubMed ID: 6212554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of fecal blood loss after use of aspirin and suprofen.
    Arnold JD; Berger AE
    Pharmacology; 1983; 27 Suppl 1():14-22. PubMed ID: 6606810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal blood loss induced by bromfenac sodium, aspirin, and placebo.
    Cohen A
    Clin Ther; 1995; 17(6):1110-7. PubMed ID: 8750402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double blind controlled study on the effect of sucralfate on gastric prostaglandin formation and microbleeding in normal and aspirin treated man.
    Konturek SJ; Kwiecień N; Obtułowicz W; Kopp B; Oleksy J
    Gut; 1986 Dec; 27(12):1450-6. PubMed ID: 3492413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of etodolac and placebo in rheumatoid arthritic patients.
    Vetter G; Placchi M; Joubert L
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):240-5. PubMed ID: 6212555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.